http://jnci.oxfordjournals.org/content/104/21/1625.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/104/21/1625" />
      <meta content="/jnci/104/21/1625.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis"
            name="DC.Title" />
      <meta content="10.1093/jnci/djs374" name="DC.Identifier" />
      <meta content="2012-11-07" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Anthony Kong" name="DC.Contributor" />
      <meta content="Nick Johnson" name="DC.Contributor" />
      <meta content="Henry C. Kitchener" name="DC.Contributor" />
      <meta content="Theresa A. Lawrie" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Anthony Kong" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Department of Oncology, University of Oxford, and Oxford University Hospitals NHS Trust, Oxford, UK (AK); Gynaecological Oncology, Royal United Hospital NHS Trust, Bath, UK (NJ); Academic Unit of Obstetrics and Gynaecology, University of Manchester, St. Mary’s Hospital, Manchester, UK (HCK); The Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Bath, UK (TAL)." />
      <meta name="citation_author" content="Nick Johnson" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Department of Oncology, University of Oxford, and Oxford University Hospitals NHS Trust, Oxford, UK (AK); Gynaecological Oncology, Royal United Hospital NHS Trust, Bath, UK (NJ); Academic Unit of Obstetrics and Gynaecology, University of Manchester, St. Mary’s Hospital, Manchester, UK (HCK); The Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Bath, UK (TAL)." />
      <meta name="citation_author" content="Henry C. Kitchener" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Department of Oncology, University of Oxford, and Oxford University Hospitals NHS Trust, Oxford, UK (AK); Gynaecological Oncology, Royal United Hospital NHS Trust, Bath, UK (NJ); Academic Unit of Obstetrics and Gynaecology, University of Manchester, St. Mary’s Hospital, Manchester, UK (HCK); The Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Bath, UK (TAL)." />
      <meta name="citation_author" content="Theresa A. Lawrie" />
      <meta name="citation_author_institution"
            content="&#xA;Affiliations of authors: Department of Oncology, University of Oxford, and Oxford University Hospitals NHS Trust, Oxford, UK (AK); Gynaecological Oncology, Royal United Hospital NHS Trust, Bath, UK (NJ); Academic Unit of Obstetrics and Gynaecology, University of Manchester, St. Mary’s Hospital, Manchester, UK (HCK); The Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Bath, UK (TAL)." />
      <meta content="Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis"
            name="citation_title" />
      <meta content="11/07/2012" name="citation_date" />
      <meta content="104" name="citation_volume" />
      <meta content="21" name="citation_issue" />
      <meta content="1625" name="citation_firstpage" />
      <meta content="1634" name="citation_lastpage" />
      <meta content="104/21/1625" name="citation_id" />
      <meta content="104/21/1625" name="citation_id_from_sass_path" />
      <meta content="jnci;104/21/1625" name="citation_mjid" />
      <meta content="10.1093/jnci/djs374" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/104/21/1625.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/104/21/1625.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/104/21/1625.full.pdf"
            name="citation_pdf_url" />
      <meta content="/content/104/21.cover.gif" name="issue_cover_image" />
      <meta content="http://jnci.oxfordjournals.org/content/104/21/1625"
            name="citation_public_url" />
      <meta content="22962693" name="citation_pmid" />
      <meta name="citation_section" content="Review" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/104/21/1624.short" rel="prev" />
      <link href="/content/104/21/1635.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d28190710e1">var callbackToken='537576D021B7014';</script><script type="text/javascript" id="session-d28190710e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:16:40.547-07:00';
            var gSessionId = 'cSov-q40zdLh5oiKCiEPlg';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/djs374");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("20121107");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F104%2F21%2F1625.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/104/21.toc">
                  <span xmlns="" class="volume-value">Volume 104</span>
                  <span xmlns="" class="issue-value"> Issue 21</span></a></li>
            <li>Pp. <span class="slug-pages">
                  1625-1634.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/104/21/1625.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Anthony+Kong&amp;sortspec=date&amp;submit=Submit">Anthony Kong</a></span><a id="xref-aff-1-1" class="xref-aff" href="#aff-1"></a><a id="xref-corresp-1-1" class="xref-corresp" href="#corresp-1"><sup>*</sup></a>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Nick+Johnson&amp;sortspec=date&amp;submit=Submit">Nick Johnson</a></span><a id="xref-aff-1-2" class="xref-aff" href="#aff-1"></a>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Henry+C.+Kitchener&amp;sortspec=date&amp;submit=Submit">Henry C. Kitchener</a></span><a id="xref-aff-1-3" class="xref-aff" href="#aff-1"></a> and 
                     </li>
                     <li class="last" id="contrib-4"><span class="name"><a class="name-search"
                              href="/search?author1=Theresa+A.+Lawrie&amp;sortspec=date&amp;submit=Submit">Theresa A. Lawrie</a></span><a id="xref-aff-1-4" class="xref-aff" href="#aff-1"></a><a id="xref-corresp-1-2" class="xref-corresp" href="#corresp-1"><sup>*</sup></a></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>
                           <strong>Affiliations of authors:</strong> Department of Oncology, University of Oxford, and Oxford University Hospitals NHS Trust, Oxford, UK (AK); Gynaecological
                           Oncology, Royal United Hospital NHS Trust, Bath, UK (NJ); Academic Unit of Obstetrics and Gynaecology, University of Manchester,
                           St. Mary’s Hospital, Manchester, UK (HCK); The Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Bath, UK
                           (TAL).
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="corresp" id="corresp-1"><a class="rev-xref" href="#xref-corresp-1-1">↵</a>
                        <sup>*</sup>Authors contributed equally to this work.
                     </li>
                     <li class="corresp" id="corresp-2">
                        <strong>Correspondence to:</strong><br /> Anthony Kong, MBBS, MRCP, FRCR, PhD, Department of Oncology, University of Oxford, and Oxford University Hospitals NHS Trust,
                        Oxford, UK (e-mail: <span class="em-link"><span class="em-addr">anthony.kong{at}oncology.ox.ac.uk</span></span>) and Theresa A. Lawrie, MBChB, PhD, The Cochrane Gynaecological Cancer Review Group, Royal United Hospital, Bath, UK (e-mail:
                        <span class="em-link"><span class="em-addr">tlawrie{at}nhs.net</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2012-04-19"><span class="received-label">Received </span>April 19, 2012.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2012-07-23"><span class="rev-recd-label">Revision received </span>July 23, 2012.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2012-07-25"><span class="accepted-label">Accepted </span>July 25, 2012.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-5" title="Methods" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <div id="sec-1" class="subsection">
                     
                     
                     <p id="p-1"><strong>Background</strong> The role of adjuvant radiotherapy in stage I endometrial cancer has changed in recent years. This updated Cochrane systematic
                        review aimed to reexamine the efficacy and toxicity of adjuvant radiotherapy vs no treatment in stage I endometrial cancer.
                     </p>
                     
                  </div>
                  
                  <div id="sec-2" class="subsection"> 
                     
                     
                     <p id="p-2"><strong>Methods</strong> We searched various databases including  The Cochrane Central Register of Controlled  Trials (CENTRAL), MEDLINE, EMBASE,
                        and the Specialised Register of the Cochrane Gynaecological Cancer Review Group (CGCRG) for randomized controlled trials that
                        met the predefined inclusion criteria. The primary outcome was overall survival (OS); secondary outcomes were endometrial
                        cancer–specific survival, locoregional recurrence, distant recurrence, and toxicity. Hazard ratios (HRs) were estimated and
                        pooled if possible; otherwise, dichotomous data were extracted. All statistical tests were two-sided.
                     </p>
                     
                  </div>
                  
                  <div id="sec-3" class="subsection">
                     
                     
                     <p id="p-3"><strong>Results</strong> Of the eight included trials, seven trials (3628 women) compared external beam radiotherapy (EBRT) and no EBRT (or vaginal
                        brachytherapy [VBT]), and one trial (645 women) compared VBT and no additional treatment. EBRT statistically significantly
                        reduced locoregional recurrence compared with no EBRT (or VBT alone) (HR = 0.36, 95% confidence Interval [CI] = 0.25 to 0.52;
                        <em>P</em> &lt; .001), but this did not translate into an improvement in OS (HR = 0.99, 95% CI = 0.82 to 1.20; <em>P</em> = .95), endometrial cancer–specific survival (HR = 0.96, 95% CI = 0.72 to 1.28; <em>P</em> = .80), or distant recurrence rates (risk ratio = 1.04, 95% CI = 0.80 to 1.35; <em>P</em> = .77). EBRT was associated with an increased risk of severe acute toxicity, severe late toxicity, and reduced quality of
                        life scores.
                     </p>
                     
                  </div>
                  
                  <div id="sec-4" class="subsection">
                     
                     
                     <p id="p-4"><strong>Conclusions</strong> EBRT reduces the risk of locoregional recurrence but has no statistically significant impact on cancer-related deaths or
                        OS. However, EBRT is associated with clinically and statistically significant morbidity and a reduction in quality of life.
                     </p>
                     
                  </div>
                  
               </div>
               <p id="p-5">This review is an update of a previously published review in The Cochrane Database of Systematic Reviews (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>,<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>). Here, we examined the role of adjuvant radiotherapy after surgery for endometrial carcinoma, a disease that affects mainly
                  postmenopausal women and is one of the most common gynecological cancers. The majority of endometrial carcinomas are diagnosed
                  at stage I in which the cancer is confined to the body of the uterus (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>). The initial treatment of stage I disease is usually a hysterectomy and bilateral salpingo-oophorectomy. Previously, it
                  was advocated that a pelvic and/or para-aortic lymphadenectomy should be performed to determine the need for adjuvant therapy.
                  However, two recent randomized trials of pelvic lymphadenectomy vs no lymphadenectomy showed no evidence of benefit for routine
                  lymphadenectomy in patients with stage I endometrial cancer (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>,<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>). The role of adjuvant radiotherapy in stage 1 endometrial cancer and early disease has changed over recent years. Previously,
                  adjuvant radiotherapy had been offered to some women who had stage 1 disease based on the perceived “risks of recurrence”
                  including histological type, grade, depth of myometrial invasion, lymphovascular invasion, and age (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>). This practice resulted in different policies of routine adjuvant radiotherapy with external beam radiotherapy (EBRT) and/or
                  vaginal brachytherapy (VBT) being offered at various treatment centers throughout the world. More recently, many centers stopped
                  offering adjuvant EBRT to women who have stage I endometrial cancer.
               </p>
               <p id="p-6" class="indent">Both pelvic EBRT and vaginal intracavitary VBT may result in acute toxicities and long-term complications, which may cause
                  worsening of quality of life for some patients (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). Therefore, the decision to offer adjuvant radiotherapy must be based on true clinical benefit, which should outweigh the
                  side effects. Our original review (<a id="xref-ref-1-2" class="xref-bibr" href="#ref-1">1</a>) combined data from four randomized controlled trials of EBRT (with or without VBT) vs no EBRT and found no evidence that
                  adjuvant EBRT improved overall survival (OS) or endometrial cancer–related survival, despite a reduction in locoregional recurrence
                  (<a id="xref-ref-1-3" class="xref-bibr" href="#ref-1">1</a>,<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>). Since then, several larger randomized trials of adjuvant radiotherapy in early endometrial carcinoma have been reported,
                  and subsequently, the less toxic VBT is increasingly used for local tumor control, even for high-risk endometrial cancer (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>). However, there is still uncertainty whether this may result in more locoregional recurrences and a reduction in patient
                  survival. Therefore, there was a need to update the Cochrane systematic review on the benefits and risks of adjuvant radiotherapy
                  to guide the clinical management of stage I endometrial cancer.
               </p>
               <div class="section methods" id="sec-5">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-10" title="Results" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Methods</h2>
                  
                  <div id="sec-6" class="subsection">
                     
                     <h3>Search Strategy</h3>
                     
                     <p id="p-7">For the original review (<a id="xref-ref-1-4" class="xref-bibr" href="#ref-1">1</a>), we searched MEDLINE and EMBASE databases from January 1, 1966 to February 10, 2006, as well as the Cochrane Register of
                        Controlled Trials, the Specialised Register of the Cochrane Gynaecological Cancer Review Group, abstracts from major international
                        scientific meetings (International Gynecologic Cancer Society, American Society of Clinical Oncology, American Society of
                        Radiation Oncology), and the US National Institute of Health clinical trial register (<a href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</a>). Further details on the search strategy and selection criteria can be found in the Appendix of the full review (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>). These searches were repeated on May 3, 2011 and January 16, 2012 for this updated review. We searched the reference lists
                        of the relevant articles, and articles in all languages were included in our study. In addition, we searched the MetaRegister
                        of Clinical Trials (<a href="http://www.controlled-trials.com/mrct/">www.controlled-trials.com/mrct/</a>) and attempted to contact investigators of past and ongoing trials for further information.
                     </p>
                     
                  </div>
                  
                  <div id="sec-7" class="subsection">
                     
                     <h3>Selection Criteria</h3>
                     
                     <p id="p-8">We included randomized controlled trials that compared surgery and EBRT with surgery alone (with or without VBT) and excluded
                        nonrandomized trials, trials of preoperative radiotherapy, sarcoma or mixed histology, when group size was less than 10 women,
                        and trials of radiotherapy vs other active treatment such as chemotherapy or hormonal therapy. At least two authors independently
                        selected studies for inclusion, and differences were resolved by discussion.
                     </p>
                     
                  </div>
                  
                  <div id="sec-8" class="subsection">
                     
                     <h3>Data Extraction and Quality Assessment</h3>
                     
                     <p id="p-9">At least two authors extracted data to prespecified data collection forms. We assessed the risk of bias (selection, detection,
                        attrition, and reporting bias) in the included studies using the Cochrane Collaboration’s tool in the Cochrane Handbook (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>). For time-to-event outcomes, we extracted hazard ratios (HR) and their associated variances, or we estimated them where
                        possible using the methods described by Parmar and colleagues (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>). Where this was not possible, we extracted dichotomous data. The data extraction was discussed and agreed by the authors,
                        and, if necessary, the authors of the trials were contacted for clarification. We also contacted the authors of included trials
                        for all data relevant to the primary and secondary outcomes.
                     </p>
                     
                  </div>
                  
                  <div id="sec-9" class="subsection">
                     
                     <h3>Statistical Analysis</h3>
                     
                     <p id="p-10">We carried out statistical analysis using the Cochrane Review Manager Software 5.1 (RevMan 5.1, Cochrane IMS, Copenhagen)
                        (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>). The generic inverse variance facility was used to combine time-to-event data to produce hazard ratios, and we produced
                        summary risk ratios (RR) with 95% confidence intervals (CI) using the Mantel Haenszel method for dichotomous data. The random
                        effects model with inverse variance weighting was used for all meta-analyses (<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>).
                     </p>
                     
                     <p id="p-11" class="indent">The staging system has undergone revision since the quoted studies have been reported (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). For the purposes of this review, we used the (before the year 2010) International Federation of Gynecology and Obstetrics
                        staging, which defines stage IA as cancer that does not invade the myometrium and is confined to the endometrium, stage IB
                        as cancer that invades less than one half of the muscle wall of the uterus, and stage IC as cancer that invades more than
                        one half of the muscle wall of the uterus (<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">3</a>). The initial protocol stated that we would carry out subgroup analyses by prognostic factors if possible. As the definitions
                        and inclusion of patients with high risk factors varied between the studies, we grouped women by the investigators’ definitions
                        of intermediate and high risk. When this was not possible, we defined women as intermediate risk if they had stage IC or grade
                        3 and as high risk if they had stage IC and grade 3. We also included high–intermediate risk women from GOG 99 in the high-risk
                        subgroup analysis. In GOG 99, the risk factors were considered as grade 3, stage 1C, increasing age, and presence of lymphovascular
                        invasion (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>). High–intermediate risk was defined as 1) at least 70 years of age with only one of the other risk factors, 2) at least
                        50 years of age with any two of the other risk factors, or 3) any age with all three of the other risk factors. All other
                        women were considered at low–intermediate risk (<a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a>). We were unable to obtain the data from the ASTEC/EN.5 study (<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>) grouped by the GOG 99 risk factors, for the high–intermediate risk subgroup analysis.
                     </p>
                     
                     <p id="p-12" class="indent">As standard radiotherapy protocols for stage I endometrial cancer may include VBT, we anticipated heterogeneity and grouped
                        the trials by control group for the purposes of investigation and clarification as follows: EBRT vs no additional treatment,
                        EBRT vs no additional treatment (with similar numbers of women in each group also receiving VBT), and EBRT vs VBT.
                     </p>
                     
                     <p id="p-13" class="indent">We performed sensitivity analyses when there was a risk of bias associated with the quality of some of the included trials
                        or when the risk of bias was unclear. In addition, we performed sensitivity analyses when potential clinical heterogeneity
                        existed without statistical heterogeneity. We assessed statistical heterogeneity in each meta-analysis by using a χ² test
                        and the <em>I</em>² statistic of inconsistency, which describes the percentage of variation across studies that is because of heterogeneity
                        rather than chance (Cochrane handbook Version 5.1.0, <a href="http://www.cochrane-handbook.org/">http://www.cochrane-handbook.org/</a>). Statistically significant heterogeneity was defined as a <em>P</em> value of less than .10 in the χ² test for heterogeneity or if <em>I</em>² was greater than 30%. All statistical tests were two-sided.
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-10">
                  <div class="section-nav"><a href="#sec-5" title="Methods" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-13" title="Discussion" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Results</h2>
                  
                  <div id="sec-11" class="subsection">
                     
                     <h3>Included Studies and Critical Appraisal</h3>
                     
                     <p id="p-14">For the original review (<a id="xref-ref-1-5" class="xref-bibr" href="#ref-1">1</a>), four studies (13 records) were selected for inclusion and 20 were excluded. The updated search (February 1, 2006 to January
                        16, 2012) identified 2165 records; of these, we selected 20 records as potentially relevant to the review (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1</a>). After independent assessment of the full text of these records, four additional studies (11 records) were included and
                        nine studies were excluded. Therefore, we included eight studies (24 reports) in this review (Aalders 1980, ASTEC/EN.5, GOG
                        99, PORTEC-1, PORTEC-2, Soderini 2003, Sorbe 2009, and Sorbe 2011) (<a id="xref-ref-6-3" class="xref-bibr" href="#ref-6">6</a>,<a id="xref-ref-15-3" class="xref-bibr" href="#ref-15">15–21</a>) and excluded 29 studies/reports. One included study (<a id="xref-ref-6-4" class="xref-bibr" href="#ref-6">6</a>) consisted of combined data from two trials (ASTEC/EN.5). We considered six of eight studies to be of a high quality. The
                        Soderini (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>) and Aalders (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>) trials were assessed as having a high and moderate risk of bias, respectively, and did not report time-to-event data, and
                        so they were excluded from the time-to-event meta-analyses. The characteristics of studies included in our analysis are listed
                        in <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>.
                     </p>
                     
                     <div id="F1" class="fig pos-float type-figure odd">
                        <div class="fig-inline"><a href="1625/F1.expansion.html"><img alt="Figure 1." src="1625/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1625/F1.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1625/F1.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/104/21/1625/F1">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 1.</span> 
                           
                           <p id="p-15" class="first-child">Selection of articles assessing the clinical outcomes of adjuvant radiotherapy for stage I endometrial carcinoma for inclusion
                              in the systematic review.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <div class="table pos-float" id="T1">
                        <div class="table-inline">
                           <div class="callout"><span>View this table:</span><ul class="callout-links">
                                 <li><a href="1625/T1.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1625/T1.expansion.html">In a new window</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="table-caption"><span class="table-label">Table 1.</span> 
                           
                           <p id="p-16" class="first-child">Summary of study characteristics and findings of randomized clinical trials included in the analysis*</p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                  </div>
                  
                  <div id="sec-12" class="subsection">
                     
                     <h3>Effects of Interventions</h3>
                     
                     <p id="p-18">
                        <em>EBRT (with or without VBT) vs no EBRT (or VBT alone)</em>. There was no statistically significant difference in OS between the EBRT treatment group and the no EBRT group (time-to-event
                        data: five trials, 2965 women; HR = 0.99, 95% CI = 0.82 to 1.20; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .95) (<a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2</a>) or endometrial cancer–specific survival (CSS) (time-to-event data: five trials, 2965 women; HR = 0.96, 95% CI = 0.72 to
                        1.28; <em>I</em><sup>2</sup> = 12%; <em>P</em> = .80) (<a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a>). External beam pelvic radiotherapy statistically significantly reduced locoregional recurrence (LRR) (time-to-event data:
                        five trials, 2965 women; HR = 0.36, 95% CI = 0.25 to 0.52; <em>I</em><sup>2</sup> = 0%; <em>P</em> &lt; .001) (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3</a>). Dichotomous data for these outcomes (including data from seven trials) produced similar results and may be found in the
                        full review in the Cochrane Library (<a id="xref-ref-10-4" class="xref-bibr" href="#ref-10">10</a>). There was no statistically significant difference in distant recurrence rates (dichotomous data; seven trials, 3628 women;
                        RR = 1.04, 95% CI = 0.80 to 1.35; <em>P</em> = .77) (<a id="xref-ref-10-5" class="xref-bibr" href="#ref-10">10</a>).
                     </p>
                     
                     <div id="F2" class="fig pos-float type-figure odd">
                        <div class="fig-inline"><a href="1625/F2.expansion.html"><img alt="Figure 2." src="1625/F2.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1625/F2.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1625/F2.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/104/21/1625/F2">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 2.</span> 
                           
                           <p id="p-19" class="first-child">Forest plot of hazard ratios (HRs) comparing overall survival (OS) for stage I endometrial carcinoma patients who received
                              external beam radiotherapy (EBRT) treatment vs those who received no EBRT treatment. HRs for each trial are represented by
                              the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated overall effect based on the meta-analysis random effect of all trials. Inverse variance (IV) and
                              random effects methods were used to calculate HRs, 95% CIs, <em>P</em> values, and the test for overall effect; these calculations were two-sided. The χ<sup>2</sup> test was used to calculate heterogeneity. Random = random effects method; SE = standard error; VBT = vaginal brachytherapy.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <div id="F3" class="fig pos-float type-figure odd">
                        <div class="fig-inline"><a href="1625/F3.expansion.html"><img alt="Figure 3." src="1625/F3.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1625/F3.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1625/F3.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/104/21/1625/F3">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 3.</span> 
                           
                           <p id="p-20" class="first-child">Forest plot of hazard ratios (HRs) comparing the locoregional recurrence for stage I endometrial carcinoma patients who received
                              external beam radiotherapy (EBRT) treatment vs those who received no EBRT treatment. HRs for each trial are represented by
                              the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated overall effect based on the meta-analysis random effect of all trials. Inverse variance (IV) and
                              random effects methods were used to calculate HRs, 95% CIs, <em>P</em> values, and the test for overall effect; these calculations were two-sided. The χ<sup>2</sup> test and the <em>I</em>
                              <sup>2</sup> statistic were used to calculate heterogeneity. Random = random effects method; SE = standard error; VBT = vaginal brachytherapy.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-21">
                        <em>Low-risk women</em>. Among low-risk women, who were defined as having grade 1 or 2 disease and less than 50% invasion, EBRT increased the risk
                        of endometrial carcinoma–related death (two trials, 517 women; RR = 2.64, 95% CI = 1.05 to 6.66; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .04) in a meta-analysis (<a id="xref-ref-10-6" class="xref-bibr" href="#ref-10">10</a>) that included only two trials (Aalders 1980, GOG 99) (<a id="xref-ref-15-5" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a>). We included data from GOG 99 (<a id="xref-ref-15-6" class="xref-bibr" href="#ref-15">15</a>) that had been defined by investigators as “low–intermediate risk.” In this trial, endometrial cancer deaths included treatment-related
                        deaths and deaths from unknown causes. There were insufficient data for a meta-analysis of other outcomes.
                     </p>
                     
                     <p id="p-22">
                        <em>Intermediate-risk women</em>. There was no statistically significant difference in OS (five studies, 2560 women; HR = 1.05, 95% CI = 0.85 to 1.31; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .63) (<a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4</a>) or CSS (five trials, 2560 women; HR = 1.03, 95% CI = 0.70 to 1.51; <em>I</em>
                        <sup>2</sup> = 25%; <em>P</em> = .90) (<a id="xref-ref-10-7" class="xref-bibr" href="#ref-10">10</a>) among intermediate-risk women (intermediate risk was defined by the investigators or was defined as stage IC or grade 3).
                        The data from the PORTEC-2 study (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>) were reported as “true high–intermediate risk” data (366 women) and included some unpublished data. We included low–intermediate
                        risk data from GOG 99 (<a id="xref-ref-15-7" class="xref-bibr" href="#ref-15">15</a>) in these subgroup analyses. If we excluded GOG 99 (<a id="xref-ref-15-8" class="xref-bibr" href="#ref-15">15</a>) from the meta-analyses, the hazard ratios for OS (HR = 1.06, 95% CI = 0.84 to 1.32; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .64) and CSS (HR = 0.97, 95% CI = 0.66 to 1.41; <em>I</em>
                        <sup>2</sup> = 21%; <em>P =</em> .86) were similar to those above (<a id="xref-ref-10-8" class="xref-bibr" href="#ref-10">10</a>). PORTEC-2 compared EBRT with VBT and showed that locoregional recurrence between the two groups was similar (5.1% vs 2.1%,
                        respectively; HR = 2.08, 95% CI = 0.71 to 6.09; <em>P</em> = .17) (<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>).
                     </p>
                     
                     <div id="F4" class="fig pos-float type-figure odd">
                        <div class="fig-inline"><a href="1625/F4.expansion.html"><img alt="Figure 4." src="1625/F4.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1625/F4.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1625/F4.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/104/21/1625/F4">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 4.</span> 
                           
                           <p id="p-23" class="first-child">Forest plot of hazard ratios (HRs) comparing the overall survival (OS) for the intermediate-risk women who received external
                              beam radiotherapy (EBRT) treatment vs those who received no EBRT treatment. HRs for each trial are represented by the <strong>squares</strong>, the size of the square represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated overall effect based on the meta-analysis random effect of all trials. Inverse variance (IV) and
                              random effects methods were used to calculate HRs, 95% CIs, <em>P</em> values, and the test for overall effect; these calculations were two-sided. The χ<sup>2</sup> test and the <em>I</em>
                              <sup>2</sup> statistic were used to calculate heterogeneity. Random = random effects method; SE = standard error; VBT = vaginal brachytherapy.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-24">
                        <em>High-risk women</em>. There was no statistically significant difference in OS (two trials, 334 women; HR = 0.91, 95% CI = 0.60 to 1.39; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .67) (<a id="xref-fig-5-1" class="xref-fig" href="#F5">Figure 5</a>) or CSS (two trials, 334 women; HR = 0.84, 95% CI = 0.51 to 1.40; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .51) among women at high risk, which was defined by the investigators or as stage IC and grade 3 (<a id="xref-ref-10-9" class="xref-bibr" href="#ref-10">10</a>). We included high–intermediate risk women from GOG 99 (<a id="xref-ref-15-9" class="xref-bibr" href="#ref-15">15</a>) in these meta-analyses. Three trials contributed data to the dichotomous meta-analyses that produced similar results for
                        this subgroup, which can be found in the full review in the Cochrane Library (<a id="xref-ref-10-10" class="xref-bibr" href="#ref-10">10</a>). When we excluded GOG 99 data (<a id="xref-ref-15-10" class="xref-bibr" href="#ref-15">15</a>) from the dichotomous meta-analyses, the results were similar to those with GOG 99 data included (<a id="xref-ref-10-11" class="xref-bibr" href="#ref-10">10</a>).
                     </p>
                     
                     <div id="F5" class="fig pos-float type-figure odd">
                        <div class="fig-inline"><a href="1625/F5.expansion.html"><img alt="Figure 5." src="1625/F5.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                                 <li><a href="1625/F5.expansion.html">In this window</a></li>
                                 <li><a class="in-nw" href="1625/F5.expansion.html">In a new window</a></li>
                              </ul>
                              <ul class="fig-services">
                                 <li class="ppt-link"><a href="/powerpoint/104/21/1625/F5">Download as PowerPoint Slide</a></li>
                              </ul>
                           </div>
                        </div>
                        <div class="fig-caption"><span class="fig-label">Figure 5.</span> 
                           
                           <p id="p-25" class="first-child">Forest plot of hazard ratios (HRs) comparing the overall survival (OS) for the high-risk women who received external beam
                              radiotherapy (EBRT) treatment vs those who received no EBRT treatment. HRs for each trial are represented by the squares,
                              the size of the <strong>square</strong> represents the weight of the trial in the meta-analysis, and the <strong>horizontal line</strong> crossing the square represents the 95% confidence interval (CI). The <strong>diamonds</strong> represent the estimated overall effect based on the meta-analysis random effect of all trials. Inverse variance (IV) and
                              random effects methods were used to calculate HRs, 95% CIs, <em>P</em> values, and the test for overall effect; these calculations were two-sided. The χ<sup>2</sup> test and the <em>I</em>
                              <sup>2</sup> statistic were used to calculate heterogeneity. Random = random effects method; SE = standard error; VBT = vaginal brachytherapy.
                           </p>
                           
                           <div class="sb-div caption-clear"></div>
                        </div>
                     </div>
                     
                     <p id="p-26">
                        <em>Long-term follow-up data</em>. Only two studies reported long-term data: PORTEC-1 (<a id="xref-ref-17-2" class="xref-bibr" href="#ref-17">17</a>) and Aalders 1980 (<a id="xref-ref-16-4" class="xref-bibr" href="#ref-16">16</a>). PORTEC-1 reported follow-up at 8, 10, and 15 years (<a id="xref-ref-17-3" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22–24</a>). When the 10-year follow-up data from PORTEC-1 and 9-year follow-up data from Aalders 1980 were combined, the relative risk
                        for OS was 1.26 (95% CI = 1.03 to 1.54; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> = .02) in favor of no EBRT (<a id="xref-ref-10-12" class="xref-bibr" href="#ref-10">10</a>).
                     </p>
                     
                     <p id="p-27">
                        <em>Toxicity and quality of life</em>. Severe acute grade 3 or 4 toxicity was more frequent in the EBRT group than in the no EBRT group and was statistically significant
                        (two trials, 1328 women; RR = 4.68, 95% CI = 1.35 to 16.16; I2 = 0%; <em>P</em> = .01), as was severe late grade 3/4 toxicity (six trials, 3501 women; RR = 2.58, 95% CI = 1.61 to 4.11; <em>I</em>
                        <sup>2</sup> = 0%; <em>P</em> &lt; .001) (<a id="xref-ref-10-13" class="xref-bibr" href="#ref-10">10</a>). Two women in the EBRT group of GOG 99 (<a id="xref-ref-15-11" class="xref-bibr" href="#ref-15">15</a>) and two in Aalders 1980 (<a id="xref-ref-16-5" class="xref-bibr" href="#ref-16">16</a>) died from radiation-related complications involving intestinal injury. One study (PORTEC-1) reported long-term adverse effects
                        and quality of life at a median follow-up of 13.3 years (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>). These investigators found that PORTEC-1 women who had received EBRT had statistically significantly higher rates (<em>P</em> &lt; .01) of urinary incontinence, diarrhea, and faecal leakage that limited their daily activities (<a id="xref-ref-17-4" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>,<a id="xref-ref-24-2" class="xref-bibr" href="#ref-24">24</a>). ERBT was also associated with statistically significantly worse “physical functioning” (<em>P</em> = .004) and “bodily pain” (<em>P</em> = .009) scores than no EBRT (<a id="xref-ref-17-5" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>,<a id="xref-ref-24-3" class="xref-bibr" href="#ref-24">24</a>).
                     </p>
                     
                     <p id="p-28">
                        <em>VBT vs no additional treatment.</em> One trial (Sorbe 2009) studied VBT vs no additional treatment in low-risk women only (<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a>). Therefore, no meta-analyses could be performed to compare OS for VBT vs no additional treatment. In this trial, there was
                        no statistically significant difference in survival between the women who received VBT compared with the control group (645
                        women, RR = 1.09, 95% CI = 0.56 to 2.11; <em>P</em> = .81) or CSS (RR = 1.43, 95% CI = 0.46 to 4.46; <em>P</em> = .54) (<a id="xref-ref-19-3" class="xref-bibr" href="#ref-19">19</a>). However, the vaginal recurrence rate in the VBT group and the control group was similar (1.2% vs 3.1%, RR = 0.39, 95% CI
                        = 0.14 to 1.09; <em>P</em> = .07) (<a id="xref-ref-19-4" class="xref-bibr" href="#ref-19">19</a>).
                     </p>
                     
                  </div>
                  
               </div>
               <div class="section" id="sec-13">
                  <div class="section-nav"><a href="#sec-10" title="Results" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-14" title="Funding" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Discussion</h2>
                  
                  <p id="p-29">Since our original review (<a id="xref-ref-1-6" class="xref-bibr" href="#ref-1">1</a>), findings from several major EBRT studies in endometrial carcinoma, including ASTEC/EN.5 (<a id="xref-ref-15-12" class="xref-bibr" href="#ref-15">15</a>), PORTEC-2 (<a id="xref-ref-18-4" class="xref-bibr" href="#ref-18">18</a>), Sorbe 2009 (<a id="xref-ref-19-5" class="xref-bibr" href="#ref-19">19</a>), and Sorbe 2011 (<a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">20</a>), have been published. We were therefore able to update our initial review and drew more definitive conclusions about adjuvant
                     radiotherapy in stage I endometrial carcinoma. Our updated review included eight trials and showed that adjuvant EBRT statistically
                     significantly reduced locoregional recurrence but not OS, endometrial CSS, or distant metastases. There were no survival benefits
                     from ERBT for women in any of the risk subgroups either. These findings appear to hold true over time (<a id="xref-ref-22-3" class="xref-bibr" href="#ref-22">22–24</a>). Furthermore, EBRT was associated with statistically significantly more severe acute toxic effects and late complications
                     (grade 3 and 4) compared with no EBRT.
                  </p>
                  
                  <p id="p-30" class="indent">It is important to note that the original Cochrane review described a nonstatistically significant trend toward a survival
                     benefit for EBRT in high-risk women (1C G3) (<a id="xref-ref-1-7" class="xref-bibr" href="#ref-1">1</a>,<a id="xref-ref-2-3" class="xref-bibr" href="#ref-2">2</a>). The ASTEC/EN.5 data (<a id="xref-ref-6-6" class="xref-bibr" href="#ref-6">6</a>) now dominate these high-risk meta-analyses (weighting of 45%–65%) and have shifted the survival hazard ratios in the direction
                     of no difference. However, the number of high-risk women participating in the reported trials of adjuvant EBRT is relatively
                     small. We cannot exclude the possibility that our analyses may lack power to detect a small advantage.
                  </p>
                  
                  <p id="p-31" class="indent">There is insufficient evidence to draw conclusions about VBT. We could find only one trial that compared VBT to no additional
                     treatment in women with low-risk disease (<a id="xref-ref-19-6" class="xref-bibr" href="#ref-19">19</a>). This study found that postoperative VBT resulted in a nonstatistically significant reduction in locoregional recurrence.
                     Compared with EBRT, VBT was effective in ensuring vaginal control in high–intermediate risk women in PORTEC-2, although the
                     locoregional relapse rate was slightly higher (2.1% vs 5.1%, <em>P</em> = .17) in the VBT group (<a id="xref-ref-18-5" class="xref-bibr" href="#ref-18">18</a>). Sorbe 2011 reported that EBRT plus VBT reduced locoregional relapse slightly more than VBT alone in intermediate-risk women
                     (1.5% vs 5%, <em>P</em> = .01) but not endometrial CSS or OS (<a id="xref-ref-20-3" class="xref-bibr" href="#ref-20">20</a>). VBT has been recommended as the adjuvant treatment of choice for women with endometrial carcinoma of intermediate (<a id="xref-ref-20-4" class="xref-bibr" href="#ref-20">20</a>) and high–intermediate risk (PORTEC-2) (<a id="xref-ref-18-6" class="xref-bibr" href="#ref-18">18</a>), respectively.
                  </p>
                  
                  <p id="p-32" class="indent">The definitions and inclusions of low risk, intermediate risk, and high risk differed between the trials included in our analyses.
                     To carry out subgroup analyses, we grouped women by the investigators’ definitions of risk. However, when this was not possible,
                     we defined women as intermediate risk if they had stage IC or grade 3 and as high risk if they had stage IC and grade 3. In
                     GOG 99, the low–intermediate risk could not be separated from the low-risk group, and their high–intermediate risk data were
                     included in the high-risk subgroup (<a id="xref-ref-15-13" class="xref-bibr" href="#ref-15">15</a>). Sensitivity analyses were performed to analyze the results with and without these included data. To assess the effect of
                     EBRT vs no EBRT, we included PORTEC-2 (<a id="xref-ref-18-7" class="xref-bibr" href="#ref-18">18</a>), although this trial directly compared EBRT with VBT and therefore VBT was not balanced between the two groups. We grouped
                     VBT with “no treatment” or the “control” group for this trial and compared EBRT vs no EBRT. However, sensitivity and subgroup
                     analyses showed that the results remained largely similar when PORTEC-2 data (<a id="xref-ref-18-8" class="xref-bibr" href="#ref-18">18</a>) were excluded, even for locoregional recurrence. Although Aalders 1980 (<a id="xref-ref-16-6" class="xref-bibr" href="#ref-16">16</a>) was undertaken before the introduction of FIGO staging, and Soderini 2003 (<a id="xref-ref-21-3" class="xref-bibr" href="#ref-21">21</a>) was only published as an abstract and a poster, we included these lower quality trials in the dichotomous data analyses,
                     which may be found in the full review (<a id="xref-ref-10-14" class="xref-bibr" href="#ref-10">10</a>). These two trials did not report time-to-event data. We performed sensitivity analyses to assess the impact of including
                     their data on the review and found that their inclusion had little impact on the overall risk ratios (<a id="xref-ref-10-15" class="xref-bibr" href="#ref-10">10</a>).
                  </p>
                  
                  <p id="p-33" class="indent">Another potential limitation of this review is that we relied on the initial histologic classification provided by the original
                     published studies. As is the case in most pragmatic randomized trials, real-time central pathology review was not performed
                     in the trials in this meta-analysis, with the exception of GOG 99 (<a id="xref-ref-15-14" class="xref-bibr" href="#ref-15">15</a>). Grading of endometrial cancer is subjective. The expert review of the pathology in the PORTEC-1 trial reclassified many
                     grade 2 tumors as grade 1 (<a id="xref-ref-23-3" class="xref-bibr" href="#ref-23">23</a>). However, there was no reclassification of most grade 3 tumors, and the regrading exercise made no difference to the summary
                     statistic in the PORTEC-1 trial (<a id="xref-ref-17-6" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-23-4" class="xref-bibr" href="#ref-23">23</a>). Some low-risk women who would not be considered for radiotherapy by today’s standard were recruited to trials, but this
                     would not affect the analysis of the data from women with high-grade tumors. The Aalders study (<a id="xref-ref-16-7" class="xref-bibr" href="#ref-16">16</a>) was conducted before the implementation of surgical staging, but there is no suggestion that the authors inadvertently recruited
                     women with advanced disease. The ASTEC/EN.5 trial (<a id="xref-ref-6-7" class="xref-bibr" href="#ref-6">6</a>) has not yet analyzed data that are based on a single expert pathology review, but patients recruited in the UK to the ASTEC
                     study (<a id="xref-ref-6-8" class="xref-bibr" href="#ref-6">6</a>) would have been reviewed by a multidisciplinary team including pathologists who had a special interest in gynecological
                     pathology. Despite the differing profiles of risk, the rates of death from disease were similar in both women participating
                     in the PORTEC-1 (<a id="xref-ref-17-7" class="xref-bibr" href="#ref-17">17</a>), PORTEC-2 (<a id="xref-ref-18-9" class="xref-bibr" href="#ref-18">18</a>), and ASTEC/EN.5 (<a id="xref-ref-6-9" class="xref-bibr" href="#ref-6">6</a>) studies. Subjective tumor grade assessments have important implications for interpretation of the data from these trials
                     but should not affect the results of our meta-analyses. Women who were diagnosed with intermediate-risk cancer are not likely
                     to benefit from EBRT, so their adjuvant options should be unaffected by a central review downgrading some of the histological
                     diagnoses. Uncertainties in the histological classification provided by the original publications will weaken the conclusions
                     from the subgroup analyses from our review. We cannot make definitive conclusions about the cost–benefit ratio for high- or
                     high–intermediate-risk disease as classified by specialist pathologists, but we can say that the accumulated randomized trial
                     data do not support the use of EBRT to improve survival in any stage 1 endometrial cancer when graded by local pathologists.
                  </p>
                  
                  <p id="p-34" class="indent">Our updated review confirms the main findings of the original review that adjuvant EBRT reduces locoregional recurrence but
                     does not improve CSS or OS in stage I endometrial carcinoma. EBRT is associated with statistically significantly increased
                     morbidity and a reduction in quality of life. In women who are at low risk, EBRT may have an adverse effect on endometrial
                     CSS. Because the locoregional recurrence rate in this subgroup is low and not statistically significantly improved by VBT,
                     VBT is probably not required in treatment of low-risk women. There is no demonstrable survival advantage from adjuvant EBRT
                     for high-risk stage I endometrial cancer, but the meta-analyses of this subgroup were underpowered and also included high–intermediate
                     risk women. This was further complicated by the lack of specialist pathologist review and errors in histological classifications
                     found in several major trials. Therefore, although there appears to be no survival benefits in the routine use of EBRT in
                     women with stage I endometrial cancer, we cannot exclude a benefit in high-risk women. This study supports the recommendations
                     of ASTEC/EN.5 (<a id="xref-ref-6-10" class="xref-bibr" href="#ref-6">6</a>) investigators that routine EBRT cannot be recommended to improve survival in women with stage I endometrial carcinoma. However,
                     further evidence may be needed to guide practice for women who are at truly high risk or high–intermediate risk as classified
                     by expert pathologists. We did not find any studies that assessed the benefits and risks of adjuvant VBT vs no additional
                     treatment in women with intermediate- or high-risk stage I endometrial cancer. We are therefore unable to draw definitive
                     conclusions about VBT in these women. However, VBT appears to be useful in preventing vaginal tumor recurrence in high–intermediate
                     subgroups compared with EBRT.
                  </p>
                  
               </div>
               <div class="section" id="sec-14">
                  <div class="section-nav"><a href="#sec-13" title="Discussion" class="prev-section-link"><span>Previous Section</span></a><a href="#notes-1" title="Notes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>Funding</h2>
                  
                  <p id="p-35">This work was funded by The Cochrane Gynaecological Cancer Review Group through the NHS Research and Development Programme,
                     Bath, UK.
                  </p>
                  
               </div>
               <div class="section notes" id="notes-1">
                  <div class="section-nav"><a href="#sec-14" title="Funding" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-15" title="Next Section" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Notes</h2>
                  
                  <div class="section" id="sec-15">
                     <div class="section-nav"><a href="#notes-1" title="Notes" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                     
                     <h3>Notes</h3>
                     
                     <p id="p-36">This systematic review is based on a Cochrane Review published in The Cochrane Library Issue 3 2012 (<a id="xref-ref-10-16" class="xref-bibr" href="#ref-10">10</a>). This review would not have been possible without the editorial support of Clare Jess, Gail Quinn, and Jane Hayes of the
                        Cochrane Gynaecological Cancer Review Group. For a complete list of acknowledgments, please refer to the Cochrane Review (<a id="xref-ref-10-17" class="xref-bibr" href="#ref-10">10</a>). The authors take full responsibility for the design of the study; the data collection, analysis, and interpretation; the
                        writing of the systematic review; and the decision to submit it for publication.
                     </p>
                     
                  </div>
                  
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">© The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: <span class="em-link"><span class="em-addr">journals.permissions{at}oup.com</span></span>.
                  </li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#sec-15" title="Previous Section" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.1">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kong</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Johnson</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Cornes</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Adjuvant radiotherapy for stage I endometrial cancer</span>
                                 <abbr class="cit-jnl-abbrev">Cochrane Database Syst Rev.</abbr>
                                 <span class="cit-pub-date">2007</span>(<span class="cit-issue">2</span>):CD003916</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Adjuvant%20radiotherapy%20for%20stage%20I%20endometrial%20cancer&amp;author=A%20Kong&amp;author=N%20Johnson&amp;author=P%20Cornes&amp;publication_year=2007&amp;journal=Cochrane%20Database%20Syst%20Rev.&amp;issue=2">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.2"
                             data-doi="10.1093/annonc/mdm066">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kong</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Simera</span>  <span class="cit-name-given-names">I</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Collingwood</span>  <span class="cit-name-given-names">M</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Williams</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kitchener</span>  <span class="cit-name-given-names">H</span></span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab">Cochrane Gynaecological Cancer Group</span>
                                 <span class="cit-article-title">Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis.</span>
                                 <abbr class="cit-jnl-abbrev">Ann Oncol</abbr>
                                 <span class="cit-pub-date">2007</span>
                                 <span class="cit-vol">18</span>(<span class="cit-issue">10</span>):<span class="cit-fpage">1595</span>–<span class="cit-lpage">1604</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=18/10/1595"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.3">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Creasman</span>  <span class="cit-name-given-names">WT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Odicino</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Maisonneuve</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Carcinoma of the corpus uteri.</span>
                                 <abbr class="cit-jnl-abbrev">J Epidemiol Biostat</abbr>
                                 <span class="cit-pub-date">2001</span>
                                 <span class="cit-vol">6</span>(<span class="cit-issue">1</span>):<span class="cit-fpage">47</span>–<span class="cit-lpage">86</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=11385776&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Carcinoma%20of%20the%20corpus%20uteri.&amp;author=WT%20Creasman&amp;author=F%20Odicino&amp;author=P%20Maisonneuve&amp;publication_year=2001&amp;journal=J%20Epidemiol%20Biostat&amp;volume=6&amp;issue=1&amp;pages=47-86">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.4">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kitchener</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Swart</span>  <span class="cit-name-given-names">AM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Qian</span>  <span class="cit-name-given-names">Q</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Amos</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Parmar</span>  <span class="cit-name-given-names">MK</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study</span>
                                 <abbr class="cit-jnl-abbrev">
                                    Lancet. </abbr>
                                 <span class="cit-pub-date">2009</span>
                                 <span class="cit-vol">373</span>(<span class="cit-issue">9658</span>):<span class="cit-fpage">125–1</span>–<span class="cit-lpage">36</span>
                                 </cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Efficacy%20of%20systematic%20pelvic%20lymphadenectomy%20in%20endometrial%20cancer%20%28MRC%20ASTEC%20trial%29%3A%20a%20randomized%20study&amp;author=H%20Kitchener&amp;author=AM%20Swart&amp;author=Q%20Qian&amp;author=C%20Amos&amp;author=MK%20Parmar&amp;publication_year=2009&amp;journal=Lancet.&amp;volume=373&amp;issue=9658&amp;pages=125%E2%80%931-36">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.5"
                             data-doi="10.1093/jnci/djn397">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Benedetti Panici</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Basile</span>  <span class="cit-name-given-names">S</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Maneschi</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.</span>
                                 <abbr class="cit-jnl-abbrev">J Natl Cancer Inst</abbr>
                                 <span class="cit-pub-date">2008</span>
                                 <span class="cit-vol">100</span>(<span class="cit-issue">23</span>):<span class="cit-fpage">1707</span>–<span class="cit-lpage">1716</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jnci&amp;resid=100/23/1707"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.6"
                             data-doi="10.1016/S0140-6736(08)61767-5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Blake</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Swart</span>  <span class="cit-name-given-names">AM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Orton</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab">ASTEC/EN.5 Study Group</span>
                                 <span class="cit-article-title">Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials):
                                    pooled trial results, systematic review, and meta-analysis.</span>
                                 <abbr class="cit-jnl-abbrev">Lancet</abbr>
                                 <span class="cit-pub-date">2009</span>
                                 <span class="cit-vol">373</span>(<span class="cit-issue">9658</span>):<span class="cit-fpage">137</span>–<span class="cit-lpage">146</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(08)61767-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19070891&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000262340900028&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Adjuvant%20external%20beam%20radiotherapy%20in%20the%20treatment%20of%20endometrial%20cancer%20%28MRC%20ASTEC%20and%20NCIC%20CTG%20EN.5%20randomised%20trials%29%3A%20pooled%20trial%20results%2C%20systematic%20review%2C%20and%20meta-analysis.&amp;author=P%20Blake&amp;author=AM%20Swart&amp;author=J%20Orton&amp;publication_year=2009&amp;journal=Lancet&amp;volume=373&amp;issue=9658&amp;pages=137-146">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text"
                           id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.7"
                             data-doi="10.1016/S0360-3016(01)01765-5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Creutzberg</span>  <span class="cit-name-given-names">CL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Putten</span>  <span class="cit-name-given-names">WL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koper</span>  <span class="cit-name-given-names">PC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab">PORTEC Study Group. The Postoperative Radiation Therapy in Endometrial Carcinoma</span>
                                 <span class="cit-article-title">The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial.</span>
                                 <abbr class="cit-jnl-abbrev">Int J Radiat Oncol Biol Phys</abbr>
                                 <span class="cit-pub-date">2001</span>
                                 <span class="cit-vol">51</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">1246</span>–<span class="cit-lpage">1255</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0360-3016(01)01765-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11728684&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000172495200010&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=The%20morbidity%20of%20treatment%20for%20patients%20with%20Stage%20I%20endometrial%20cancer%3A%20results%20from%20a%20randomized%20trial.&amp;author=CL%20Creutzberg&amp;author=WL%20van%20Putten&amp;author=PC%20Koper&amp;publication_year=2001&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;volume=51&amp;issue=5&amp;pages=1246-1255">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.8"
                             data-doi="10.1016/j.ygyno.2009.06.027">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">McCloskey</span>  <span class="cit-name-given-names">SA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Tchabo</span>  <span class="cit-name-given-names">NE</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Malhotra</span>  <span class="cit-name-given-names">HK</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials
                                    of adjuvant pelvic radiation.</span>
                                 <abbr class="cit-jnl-abbrev">Gynecol Oncol</abbr>
                                 <span class="cit-pub-date">2010</span>
                                 <span class="cit-vol">116</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">404</span>–<span class="cit-lpage">407</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ygyno.2009.06.027&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19944453&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Adjuvant%20vaginal%20brachytherapy%20alone%20for%20high%20risk%20localized%20endometrial%20cancer%20as%20defined%20by%20the%20three%20major%20randomized%20trials%20of%20adjuvant%20pelvic%20radiation.&amp;author=SA%20McCloskey&amp;author=NE%20Tchabo&amp;author=HK%20Malhotra&amp;publication_year=2010&amp;journal=Gynecol%20Oncol&amp;volume=116&amp;issue=3&amp;pages=404-407">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.9"
                             data-doi="10.1111/j.1525-1438.2008.01198.x">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Atahan</span>  <span class="cit-name-given-names">IL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Ozyar</span>  <span class="cit-name-given-names">E</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Yildiz</span>  <span class="cit-name-given-names">F</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after
                                    radical surgery.</span>
                                 <abbr class="cit-jnl-abbrev">Int J Gynecol Cancer</abbr>
                                 <span class="cit-pub-date">2008</span>
                                 <span class="cit-vol">18</span>(<span class="cit-issue">6</span>):<span class="cit-fpage">1294</span>–<span class="cit-lpage">1299</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/j.1525-1438.2008.01198.x&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=18284452&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Vaginal%20high%20dose%20rate%20brachytherapy%20alone%20in%20patients%20with%20intermediate-%20to%20high-risk%20stage%20I%20endometrial%20carcinoma%20after%20radical%20surgery.&amp;author=IL%20Atahan&amp;author=E%20Ozyar&amp;author=F%20Yildiz&amp;publication_year=2008&amp;journal=Int%20J%20Gynecol%20Cancer&amp;volume=18&amp;issue=6&amp;pages=1294-1299">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.10">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kong</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Johnson</span>  <span class="cit-name-given-names">N</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kitchener</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lawrie</span>  <span class="cit-name-given-names">T</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Adjuvant radiotherapy for stage I endometrial cancer</span>
                                 <abbr class="cit-jnl-abbrev">
                                    Cochrane Database Syst Rev. 
                                    </abbr>
                                 <span class="cit-pub-date">2012</span>(<span class="cit-issue">3</span>):CD003916</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Adjuvant%20radiotherapy%20for%20stage%20I%20endometrial%20cancer&amp;author=A%20Kong&amp;author=N%20Johnson&amp;author=H%20Kitchener&amp;author=T%20Lawrie&amp;publication_year=2012&amp;journal=Cochrane%20Database%20Syst%20Rev.%20&amp;issue=3">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.11">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival
                                          endpoints. Stat Med. 1998;17(24):2815–2834</span></span></li>
                              </ol><cite>–
                                 </cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?author=Parmar%20MK%2C%20Torri%20V%2C%20Stewart%20L.%20Extracting%20summary%20statistics%20to%20perform%20meta-analyses%20of%20the%20published%20literature%20for%20survival%20endpoints.%20Stat%20Med.%201998%3B17%2824%29%3A2815%E2%80%932834">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text"
                           id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.12">
                           <div class="cit-metadata"><cite><span class="cit-auth cit-collab">Review Manager (Rev Man) [computer program]</span>. version 5.1. <span class="cit-article-title">Copenhagen</span>
                                 <abbr class="cit-jnl-abbrev">The Nordic Cochrane Centre, The Cochrane Collaboration,</abbr>
                                 <span class="cit-pub-date">2011</span> [database on the Internet]</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.13"
                             data-doi="10.1016/0197-2456(86)90046-2">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">DerSimonian</span>  <span class="cit-name-given-names">R</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Laird</span>  <span class="cit-name-given-names">N</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Meta-analysis in clinical trials.</span>
                                 <abbr class="cit-jnl-abbrev">Control Clin Trials</abbr>
                                 <span class="cit-pub-date">1986</span>
                                 <span class="cit-vol">7</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">177</span>–<span class="cit-lpage">188</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0197-2456(86)90046-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=3802833&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1986F013900001&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Meta-analysis%20in%20clinical%20trials.&amp;author=R%20DerSimonian&amp;author=N%20Laird&amp;publication_year=1986&amp;journal=Control%20Clin%20Trials&amp;volume=7&amp;issue=3&amp;pages=177-188">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text"
                           id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.14"
                             data-doi="10.1097/GRF.0b013e3182185baa">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lewin</span>  <span class="cit-name-given-names">SN</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Revised FIGO staging system for endometrial cancer.</span>
                                 <abbr class="cit-jnl-abbrev">Clin Obstet Gynecol</abbr>
                                 <span class="cit-pub-date">2011</span>
                                 <span class="cit-vol">54</span>(<span class="cit-issue">2</span>):<span class="cit-fpage">215</span>–<span class="cit-lpage">218</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1097/GRF.0b013e3182185baa&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21508690&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Revised%20FIGO%20staging%20system%20for%20endometrial%20cancer.&amp;author=SN%20Lewin&amp;publication_year=2011&amp;journal=Clin%20Obstet%20Gynecol&amp;volume=54&amp;issue=2&amp;pages=215-218">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text"
                           id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.15"
                             data-doi="10.1016/j.ygyno.2003.11.048">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Keys</span>  <span class="cit-name-given-names">HM</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Roberts</span>  <span class="cit-name-given-names">JA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Brunetto</span>  <span class="cit-name-given-names">VL</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab"> Gynecologic Oncology Group</span>
                                 <span class="cit-article-title">A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial
                                    adenocarcinoma: a Gynecologic Oncology Group study.</span>
                                 <abbr class="cit-jnl-abbrev">Gynecol Oncol</abbr>
                                 <span class="cit-pub-date">2004</span>
                                 <span class="cit-vol">92</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">744</span>–<span class="cit-lpage">751</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ygyno.2003.11.048&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=14984936&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000220057700003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=A%20phase%20III%20trial%20of%20surgery%20with%20or%20without%20adjunctive%20external%20pelvic%20radiation%20therapy%20in%20intermediate%20risk%20endometrial%20adenocarcinoma%3A%20a%20Gynecologic%20Oncology%20Group%20study.&amp;author=HM%20Keys&amp;author=JA%20Roberts&amp;author=VL%20Brunetto&amp;publication_year=2004&amp;journal=Gynecol%20Oncol&amp;volume=92&amp;issue=3&amp;pages=744-751">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text"
                           id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.16">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Aalders</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Abeler</span>  <span class="cit-name-given-names">V</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Kolstad</span>  <span class="cit-name-given-names">P</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Onsrud</span>  <span class="cit-name-given-names">M</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic
                                    study of 540 patients.</span>
                                 <abbr class="cit-jnl-abbrev">Obstet Gynecol</abbr>
                                 <span class="cit-pub-date">1980</span>
                                 <span class="cit-vol">56</span>(<span class="cit-issue">4</span>):<span class="cit-fpage">419</span>–<span class="cit-lpage">427</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=6999399&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1980KJ99700004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Postoperative%20external%20irradiation%20and%20prognostic%20parameters%20in%20stage%20I%20endometrial%20carcinoma%3A%20clinical%20and%20histopathologic%20study%20of%20540%20patients.&amp;author=J%20Aalders&amp;author=V%20Abeler&amp;author=P%20Kolstad&amp;author=M%20Onsrud&amp;publication_year=1980&amp;journal=Obstet%20Gynecol&amp;volume=56&amp;issue=4&amp;pages=419-427">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-2" title="View reference 17. in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.17"
                             data-doi="10.1016/S0140-6736(00)02139-5">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Creutzberg</span>  <span class="cit-name-given-names">CL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Putten</span>  <span class="cit-name-given-names">WL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Koper</span>  <span class="cit-name-given-names">PC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised
                                    trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.</span>
                                 <abbr class="cit-jnl-abbrev">Lancet</abbr>
                                 <span class="cit-pub-date">2000</span>
                                 <span class="cit-vol">355</span>(<span class="cit-issue">9213</span>):<span class="cit-fpage">1404</span>–<span class="cit-lpage">1411</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(00)02139-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10791524&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000086829800011&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Surgery%20and%20postoperative%20radiotherapy%20versus%20surgery%20alone%20for%20patients%20with%20stage-1%20endometrial%20carcinoma%3A%20multicentre%20randomised%20trial.%20PORTEC%20Study%20Group.%20Post%20Operative%20Radiation%20Therapy%20in%20Endometrial%20Carcinoma.&amp;author=CL%20Creutzberg&amp;author=WL%20van%20Putten&amp;author=PC%20Koper&amp;publication_year=2000&amp;journal=Lancet&amp;volume=355&amp;issue=9213&amp;pages=1404-1411">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-2" title="View reference 18. in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.18"
                             data-doi="10.1016/S0140-6736(09)62163-2">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nout</span>  <span class="cit-name-given-names">RA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Smit</span>  <span class="cit-name-given-names">VT</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Putter</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab"> PORTEC Study Group</span>
                                 <span class="cit-article-title">Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk
                                    (PORTEC-2): an open-label, non-inferiority, randomised trial.</span>
                                 <abbr class="cit-jnl-abbrev">Lancet</abbr>
                                 <span class="cit-pub-date">2010</span>
                                 <span class="cit-vol">375</span>(<span class="cit-issue">9717</span>):<span class="cit-fpage">816</span>–<span class="cit-lpage">823</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(09)62163-2&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=20206777&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000275682600031&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Vaginal%20brachytherapy%20versus%20pelvic%20external%20beam%20radiotherapy%20for%20patients%20with%20endometrial%20cancer%20of%20high-intermediate%20risk%20%28PORTEC-2%29%3A%20an%20open-label%2C%20non-inferiority%2C%20randomised%20trial.&amp;author=RA%20Nout&amp;author=VT%20Smit&amp;author=H%20Putter&amp;publication_year=2010&amp;journal=Lancet&amp;volume=375&amp;issue=9717&amp;pages=816-823">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-2" title="View reference 19. in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.19"
                             data-doi="10.1111/IGC.0b013e3181a6c9df">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sorbe</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nordström</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Mäenpää</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study.</span>
                                 <abbr class="cit-jnl-abbrev">Int J Gynecol Cancer</abbr>
                                 <span class="cit-pub-date">2009</span>
                                 <span class="cit-vol">19</span>(<span class="cit-issue">5</span>):<span class="cit-fpage">873</span>–<span class="cit-lpage">878</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1111/IGC.0b013e3181a6c9df&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=19574776&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000267980800013&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Intravaginal%20brachytherapy%20in%20FIGO%20stage%20I%20low-risk%20endometrial%20cancer%3A%20a%20controlled%20randomized%20study.&amp;author=B%20Sorbe&amp;author=B%20Nordstr%C3%B6m&amp;author=J%20M%C3%A4enp%C3%A4%C3%A4&amp;publication_year=2009&amp;journal=Int%20J%20Gynecol%20Cancer&amp;volume=19&amp;issue=5&amp;pages=873-878">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-2" title="View reference 20. in text"
                           id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.20"
                             data-doi="10.1016/j.ijrobp.2011.04.014">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sorbe</span>  <span class="cit-name-given-names">B</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Horvath</span>  <span class="cit-name-given-names">G</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Andersson</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Boman</span>  <span class="cit-name-given-names">K</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lundgren</span>  <span class="cit-name-given-names">C</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Pettersson</span>  <span class="cit-name-given-names">B</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial
                                    carcinoma–a prospective randomized study.</span>
                                 <abbr class="cit-jnl-abbrev">Int J Radiat Oncol Biol Phys</abbr>
                                 <span class="cit-pub-date">2012</span>
                                 <span class="cit-vol">82</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">1249</span>–<span class="cit-lpage">1255</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ijrobp.2011.04.014&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=21676554&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=External%20pelvic%20and%20vaginal%20irradiation%20versus%20vaginal%20irradiation%20alone%20as%20postoperative%20therapy%20in%20medium-risk%20endometrial%20carcinoma%E2%80%93a%20prospective%20randomized%20study.&amp;author=B%20Sorbe&amp;author=G%20Horvath&amp;author=H%20Andersson&amp;author=K%20Boman&amp;author=C%20Lundgren&amp;author=B%20Pettersson&amp;publication_year=2012&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;volume=82&amp;issue=3&amp;pages=1249-1255">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text"
                           id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.21">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Soderini</span>  <span class="cit-name-given-names">A</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Anchezar</span>  <span class="cit-name-given-names">J</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Sardi</span>  <span class="cit-name-given-names">J</span></span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Role of adjuvant radiotherapy (RT) in intermediate risk (1b G2-3-1C) endometrioid carcinoma (EC) after extended staging surgery
                                    (ESS). Preliminary reports of a randomized trial</span>
                                 <abbr class="cit-jnl-abbrev">Int J Gynecol Cancer.</abbr>
                                 <span class="cit-pub-date">2003</span>
                                 <span class="cit-vol">13</span>(suppl 1):Abstract P0147:78</cite></div>
                           <div class="cit-extra"><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Role%20of%20adjuvant%20radiotherapy%20%28RT%29%20in%20intermediate%20risk%20%281b%20G2-3-1C%29%20endometrioid%20carcinoma%20%28EC%29%20after%20extended%20staging%20surgery%20%28ESS%29.%20Preliminary%20reports%20of%20a%20randomized%20trial&amp;author=A%20Soderini&amp;author=J%20Anchezar&amp;author=J%20Sardi&amp;publication_year=2003&amp;journal=Int%20J%20Gynecol%20Cancer.&amp;volume=13">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-2" title="View reference 22. in text"
                           id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.22"
                             data-doi="10.1200/JCO.2004.08.159">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Creutzberg</span>  <span class="cit-name-given-names">CL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Putten</span>  <span class="cit-name-given-names">WL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Wárlám-Rodenhuis</span>  <span class="cit-name-given-names">CC</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab"> Postoperative Radiation Therapy in Endometrial Carcinoma Trial</span>
                                 <span class="cit-article-title">Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation
                                    Therapy in Endometrial Carcinoma Trial.</span>
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>
                                 <span class="cit-pub-date">2004</span>
                                 <span class="cit-vol">22</span>(<span class="cit-issue">7</span>):<span class="cit-fpage">1234</span>–<span class="cit-lpage">1241</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=22/7/1234"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text"
                           id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.23"
                             data-doi="10.1016/j.ijrobp.2005.03.007">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Scholten</span>  <span class="cit-name-given-names">AN</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van Putten</span>  <span class="cit-name-given-names">WL</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Beerman</span>  <span class="cit-name-given-names">H</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-auth cit-collab"> PORTEC Study Group</span>
                                 <span class="cit-article-title">Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central
                                    pathology review.</span>
                                 <abbr class="cit-jnl-abbrev">Int J Radiat Oncol Biol Phys</abbr>
                                 <span class="cit-pub-date">2005</span>
                                 <span class="cit-vol">63</span>(<span class="cit-issue">3</span>):<span class="cit-fpage">834</span>–<span class="cit-lpage">838</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/j.ijrobp.2005.03.007&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=15927414&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000232411600024&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a><a target="_blank"
                                 href="http://scholar.google.com/scholar_lookup?title=Postoperative%20radiotherapy%20for%20Stage%201%20endometrial%20carcinoma%3A%20long-term%20outcome%20of%20the%20randomized%20PORTEC%20trial%20with%20central%20pathology%20review.&amp;author=AN%20Scholten&amp;author=WL%20van%20Putten&amp;author=H%20Beerman&amp;publication_year=2005&amp;journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;volume=63&amp;issue=3&amp;pages=834-838">Google Scholar</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-journal" id="cit-104.21.1625.24"
                             data-doi="10.1200/JCO.2010.32.4590">
                           <div class="cit-metadata">
                              <ol class="cit-auth-list">
                                 <li><span class="cit-auth"><span class="cit-name-surname">Nout</span>  <span class="cit-name-given-names">RA</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">van de Poll-Franse</span>  <span class="cit-name-given-names">LV</span></span>, 
                                 </li>
                                 <li><span class="cit-auth"><span class="cit-name-surname">Lybeert</span>  <span class="cit-name-given-names">ML</span></span>, 
                                 </li>
                                 <li><span class="cit-etal">et al.</span></li>
                              </ol><cite>
                                 <span class="cit-article-title">Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in
                                    the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial.</span>
                                 <abbr class="cit-jnl-abbrev">J Clin Oncol</abbr>
                                 <span class="cit-pub-date">2011</span>
                                 <span class="cit-vol">29</span>(<span class="cit-issue">13</span>):<span class="cit-fpage">1692</span>–<span class="cit-lpage">1700</span>
                                 </cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=29/13/1692"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div id="related">
               <h2>Related articles</h2>
               <ul class="related-list">
                  <div class="cit has-earlier-version">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">Solicited Editorial<span class="cit-sep cit-sep-after-article-section">:</span> </span><ul class="cit-auth-list">
                           <li class="first-item"><span class="cit-auth cit-auth-type-author">Patricia J. Eifel</span></li>  
                        </ul><span class="cit-title">The Role of Adjuvant Radiation Therapy for Stage I Endometrial Cancer: Does Meta-Analysis Reveal the Answer? </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2012<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">104 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>21<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-pages"><span class="cit-first-page">1615</span><span class="cit-sep">-</span><span class="cit-last-page">1616</span> </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/djs434 </span><span class="cit-ahead-of-print-date"><span class="cit-sep cit-sep-before-article-ahead-of-print-date">first published online </span>October 26, 2012 </span><span class="cit-page-count"><span class="cit-sep cit-sep-before-article-page-count">(</span>2<span class="cit-sep cit-sep-after-article-page-count"> pages)</span> </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;104/21/1615 pdf_extract,full,reprint"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/104/21/1615.extract" rel="extract">Extract</a></li>
                           <li><a href="/content/104/21/1615.full" rel="full-text">Full Text (HTML)</a></li>
                           <li class="last-item"><a href="/content/104/21/1615.full.pdf+html" rel="full-text.pdf">Full Text (PDF)</a></li>
                        </ul>  
                     </div> 
                  </div>
               </ul>
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/104/21/1624.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/104/21/1635.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/104/21.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2012) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    104
                                    </span><span class="slug-issue">
                                    (21):
                                    </span><span class="slug-pages">
                                    1625-1634.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/djs374" class="slug-doi">10.1093/jnci/djs374</span>
                                    </span>
                                 </cite>
                              
                              
                              <span class="slug-metadata-note ahead-of-print">
                                 
                                 First published online
                                 
                                 <span class="slug-ahead-of-print-date">September 6, 2012</span>
                                 </span>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/104/21/1625.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/104/21/1625.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                        <li class="cb-versions">
                           <div><span id="pap-all-versions-label">All Versions of this Article:</span><ol class="version-list">
                                 <li><a href="/content/early/2012/09/06/jnci.djs374">djs374v1</a></li>
                                 <li class="current-li"><span>104/21/1625</span> <span class="current-version">most recent</span></li>
                              </ol>
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=Review&amp;sortspec=date&amp;submit=Submit">Review</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;104/21/1625" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B104%2F21%2F1625&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/104/21/1625.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=104/21/1625&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/104/21/1625.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3Bdjs374&amp;citation=Kong%20et%20al.%20104%20%2821%29:%201625&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B104%2F21%2F1625&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=22962693&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B104%2F21%2F1625">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B104%2F21%2F1625">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis%3A%20&amp;publicationDate=11%2F07%2F2012&amp;author=Anthony%20Kong%2C%20Nick%20Johnson%2C%20Henry%20C.%20Kitchener%2C%20Theresa%20A.%20Lawrie&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdjs374&amp;volumeNum=104&amp;issueNum=21&amp;startPage=1625&amp;endPage=1634&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/104/21/1625.full?cited-by=yes&amp;legid=jnci;104/21/1625#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/104/21/1625" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/104/21/1625?access_num=/jnci/104/21/1625"
                              rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F104%2F21%2F1625&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/104/21/1625.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AKong%20author%3AA.%22"
                              class="cb-art-gs-auth author-link">Articles by  Kong, A.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ALawrie%20author%3AT.A.%22"
                              class="cb-art-gs-auth author-link">Articles by  Lawrie, T. A.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/104/21/1625.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=22962693&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Kong%20A&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Kong, A.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Johnson%20N&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Johnson, N.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Kitchener%20HC&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Kitchener, H. C.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Lawrie%20TA&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Lawrie, T. A.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="#related">Related articles in this journal</a></li>
                        <li><a href="/content/104/21/1625.full?related-urls=yes&amp;legid=jnci;104/21/1625#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B104%2F21%2F1625&amp;current-view-path=/content/104/21/1625.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/104/21/1625&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis+--+Kong%20et%20al.%20104%20%2821%29%3A%201625+--+jnci.j&amp;doi=10.1093/jnci/djs374&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/104/21/1625&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis+--+Kong%20et%20al.%20104%20%2821%29%3A%201625+--+jnci.j&amp;doi=10.1093/jnci/djs374&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/104/21/1625&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis+--+Kong%20et%20al.%20104%20%2821%29%3A%201625+--+jnci.j&amp;doi=10.1093/jnci/djs374&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/104/21/1625&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis+--+Kong%20et%20al.%20104%20%2821%29%3A%201625+--+jnci.j&amp;doi=10.1093/jnci/djs374&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/104/21/1625&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis+--+Kong%20et%20al.%20104%20%2821%29%3A%201625+--+jnci.j&amp;doi=10.1093/jnci/djs374&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/104/21/1625&amp;title=Adjuvant%20Radiotherapy%20for%20Stage%20I%20Endometrial%20Cancer%3A%20An%20Updated%20Cochrane%20Systematic%20Review%20and%20Meta-analysis+--+Kong%20et%20al.%20104%20%2821%29%3A%201625+--+jnci.j&amp;doi=10.1093/jnci/djs374&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-5">Methods</a></li>
                        <li><a href="#sec-10">Results</a></li>
                        <li><a href="#sec-13">Discussion</a></li>
                        <li><a href="#sec-14">Funding</a></li>
                        <li><a href="#notes-1">Notes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/104/21/1625.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/104/21/1625.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>